A REVIEW OF SODIUM PENTOBARBITAL (NAP)

Contraindicated (1)pentobarbital will minimize the extent or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers can lead to diminished serum concentrations and loss of antimalarial efficacypentobarbital will decrease the level or effect of oxybutynin by affe